Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Generic Capital Corporation is a private merchant banking and venture capital firm headquartered in Toronto, Canada, that specializes in the life sciences, technology, and natural resources sectors. The firm provides essential early-stage capital, strategic advisory services, and corporate restructuring expertise to growth-oriented companies. Generic Capital is particularly recognized for its proficiency in navigating the Canadian capital markets, frequently facilitating public listings through Initial Public Offerings (IPOs) and Reverse Takeovers (RTOs) on the TSX Venture Exchange. By acting as a bridge between innovative startups and public investors, the company plays a vital role in the development and financing of the North American biotech and healthcare ecosystem. Led by President David Rosenkrantz, the firm leverages its extensive network to support companies from their initial formation through to their maturity as public entities.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Generic Capital Corporation.